Kabuki Syndrome: History
View Latest Version
Please note this is an old version of this entry, which may differ significantly from the current revision.
Subjects: Genetics & Heredity
Contributor:
Camila Xu

Kabuki syndrome is a disorder that affects many parts of the body. It is characterized by distinctive facial features including arched eyebrows; long eyelashes; long openings of the eyelids (long palpebral fissures) with the lower lids turned out (everted) at the outside edges; a flat, broadened tip of the nose; and large protruding earlobes. The name of this disorder comes from the resemblance of its characteristic facial appearance to stage makeup used in traditional Japanese Kabuki theater.

  • genetic conditions

1. Introduction

People with Kabuki syndrome have mild to severe developmental delay and intellectual disability. Affected individuals may also have seizures, an unusually small head size (microcephaly), or weak muscle tone (hypotonia). Some have eye problems such as rapid, involuntary eye movements (nystagmus) or eyes that do not look in the same direction (strabismus).

Other characteristic features of Kabuki syndrome include short stature and skeletal abnormalities such as abnormal side-to-side curvature of the spine (scoliosis), short fifth (pinky) fingers, or problems with the hip and knee joints. The roof of the mouth may have an abnormal opening (cleft palate) or be high and arched, and dental problems are common in affected individuals. People with Kabuki syndrome may also have fingerprints with unusual features and fleshy pads at the tips of the fingers. These prominent finger pads are called fetal finger pads because they normally occur in human fetuses; in most people they disappear before birth.

A wide variety of other health problems occur in some people with Kabuki syndrome. Among the most commonly reported are heart abnormalities, frequent ear infections (otitis media), hearing loss, and early puberty.

2. Frequency

Kabuki syndrome occurs in approximately 1 in 32,000 newborns.

3. Causes

Kabuki syndrome is caused by mutations in the KMT2D gene (also known as MLL2) or the KDM6A gene.

Between 55 and 80 percent of cases of Kabuki syndrome are caused by mutations in the KMT2D gene. This gene provides instructions for making an enzyme called lysine-specific methyltransferase 2D that is found in many organs and tissues of the body. Lysine-specific methyltransferase 2D functions as a histone methyltransferase. Histone methyltransferases are enzymes that modify proteins called histones. Histones are structural proteins that attach (bind) to DNA and give chromosomes their shape. By adding a molecule called a methyl group to histones (a process called methylation), histone methyltransferases control (regulate) the activity of certain genes. Lysine-specific methyltransferase 2D appears to activate certain genes that are important for development.

Between 2 and 6 percent of cases of Kabuki syndrome are caused by mutations in the KDM6A gene. This gene provides instructions for making an enzyme called lysine-specific demethylase 6A. This enzyme is a histone demethylase, which means that it helps to remove methyl groups from certain histones. Like lysine-specific methyltransferase 2D, lysine-specific demethylase 6A regulates the activity of certain genes, and research suggests that the two enzymes work together to control certain developmental processes.

The KMT2D and KDM6A gene mutations associated with Kabuki syndrome lead to the absence of the corresponding functional enzyme. A lack of the enzymes produced from these genes disrupts normal histone methylation and impairs proper activation of certain genes in many of the body's organs and tissues, resulting in the abnormalities of development and function characteristic of Kabuki syndrome.

Some people with Kabuki syndrome have no identified KMT2D or KDM6A gene mutation. The cause of the disorder in these individuals is unknown.

3.1. The genes associated with Kabuki syndrome

  • KDM6A

  • KMT2D

4. Inheritance

When Kabuki syndrome is caused by mutations in the KMT2D gene, it is inherited in an autosomal dominant pattern, which means one copy of the altered gene in each cell is sufficient to cause the disorder.

When Kabuki syndrome is caused by mutations in the KDM6A gene, it is inherited in an X-linked dominant pattern. The KDM6A gene is located on the X chromosome, which is one of the two sex chromosomes. In females (who have two X chromosomes), a mutation in one of the two copies of the gene in each cell is sufficient to cause the disorder. In males (who have only one X chromosome), a mutation in the only copy of the gene in each cell causes the disorder. A characteristic of X-linked inheritance is that fathers cannot pass X-linked traits to their sons.

Most cases of Kabuki syndrome result from a new mutation in one of these genes and occur in people with no history of the disorder in their family. In a few cases, an affected person is believed to have inherited the mutation from one affected parent.

5. Other Names for This Condition

  • Kabuki make-up syndrome

  • Kabuki makeup syndrome

  • KMS

  • Niikawa-Kuroki syndrome

This entry is adapted from the peer-reviewed paper https://medlineplus.gov/genetics/condition/kabuki-syndrome

References

  1. Banka S, Lederer D, Benoit V, Jenkins E, Howard E, Bunstone S, Kerr B, McKeeS, Lloyd IC, Shears D, Stewart H, White SM, Savarirayan R, Mancini GM, Beysen D, Cohn RD, Grisart B, Maystadt I, Donnai D. Novel KDM6A (UTX) mutations and aclinical and molecular review of the X-linked Kabuki syndrome (KS2). Clin Genet. 2015 Mar;87(3):252-8. doi: 10.1111/cge.12363.
  2. Bokinni Y. Kabuki syndrome revisited. J Hum Genet. 2012 Apr;57(4):223-7. doi: 10.1038/jhg.2012.28.
  3. Bögershausen N, Wollnik B. Unmasking Kabuki syndrome. Clin Genet. 2013Mar;83(3):201-11. doi: 10.1111/cge.12051.
  4. Dentici ML, Di Pede A, Lepri FR, Gnazzo M, Lombardi MH, Auriti C, Petrocchi S,Pisaneschi E, Bellacchio E, Capolino R, Braguglia A, Angioni A, Dotta A, Digilio MC, Dallapiccola B. Kabuki syndrome: clinical and molecular diagnosis in thefirst year of life. Arch Dis Child. 2015 Feb;100(2):158-64. doi:10.1136/archdischild-2013-305858.
  5. Kuniba H, Yoshiura K, Kondoh T, Ohashi H, Kurosawa K, Tonoki H, Nagai T,Okamoto N, Kato M, Fukushima Y, Kaname T, Naritomi K, Matsumoto T, Moriuchi H,Kishino T, Kinoshita A, Miyake N, Matsumoto N, Niikawa N. Molecular karyotypingin 17 patients and mutation screening in 41 patients with Kabuki syndrome. J Hum Genet. 2009 May;54(5):304-9. doi: 10.1038/jhg.2009.30.
  6. Lederer D, Grisart B, Digilio MC, Benoit V, Crespin M, Ghariani SC, MaystadtI, Dallapiccola B, Verellen-Dumoulin C. Deletion of KDM6A, a histone demethylase interacting with MLL2, in three patients with Kabuki syndrome. Am J Hum Genet.2012 Jan 13;90(1):119-24. doi: 10.1016/j.ajhg.2011.11.021.
  7. Liu S, Hong X, Shen C, Shi Q, Wang J, Xiong F, Qiu Z. Kabuki syndrome: aChinese case series and systematic review of the spectrum of mutations. BMC MedGenet. 2015 Apr 21;16:26. doi: 10.1186/s12881-015-0171-4. Review.
  8. Micale L, Augello B, Maffeo C, Selicorni A, Zucchetti F, Fusco C, De Nittis P,Pellico MT, Mandriani B, Fischetto R, Boccone L, Silengo M, Biamino E, Perria C, Sotgiu S, Serra G, Lapi E, Neri M, Ferlini A, Cavaliere ML, Chiurazzi P, MonicaMD, Scarano G, Faravelli F, Ferrari P, Mazzanti L, Pilotta A, Patricelli MG,Bedeschi MF, Benedicenti F, Prontera P, Toschi B, Salviati L, Melis D, DiBattista E, Vancini A, Garavelli L, Zelante L, Merla G. Molecular analysis,pathogenic mechanisms, and readthrough therapy on a large cohort of Kabukisyndrome patients. Hum Mutat. 2014 Jul;35(7):841-50. doi: 10.1002/humu.22547.
  9. Miyake N, Koshimizu E, Okamoto N, Mizuno S, Ogata T, Nagai T, Kosho T, Ohashi H, Kato M, Sasaki G, Mabe H, Watanabe Y, Yoshino M, Matsuishi T, Takanashi J,Shotelersuk V, Tekin M, Ochi N, Kubota M, Ito N, Ihara K, Hara T, Tonoki H, Ohta T, Saito K, Matsuo M, Urano M, Enokizono T, Sato A, Tanaka H, Ogawa A, Fujita T, Hiraki Y, Kitanaka S, Matsubara Y, Makita T, Taguri M, Nakashima M, Tsurusaki Y, Saitsu H, Yoshiura K, Matsumoto N, Niikawa N. MLL2 and KDM6A mutations inpatients with Kabuki syndrome. Am J Med Genet A. 2013 Sep;161A(9):2234-43. doi:10.1002/ajmg.a.36072.
  10. Miyake N, Mizuno S, Okamoto N, Ohashi H, Shiina M, Ogata K, Tsurusaki Y,Nakashima M, Saitsu H, Niikawa N, Matsumoto N. KDM6A point mutations cause Kabukisyndrome. Hum Mutat. 2013 Jan;34(1):108-10. doi: 10.1002/humu.22229.
  11. Ng SB, Bigham AW, Buckingham KJ, Hannibal MC, McMillin MJ, Gildersleeve HI,Beck AE, Tabor HK, Cooper GM, Mefford HC, Lee C, Turner EH, Smith JD, Rieder MJ, Yoshiura K, Matsumoto N, Ohta T, Niikawa N, Nickerson DA, Bamshad MJ, Shendure J.Exome sequencing identifies MLL2 mutations as a cause of Kabuki syndrome. NatGenet. 2010 Sep;42(9):790-3. doi: 10.1038/ng.646.
  12. Paulussen AD, Stegmann AP, Blok MJ, Tserpelis D, Posma-Velter C, Detisch Y,Smeets EE, Wagemans A, Schrander JJ, van den Boogaard MJ, van der Smagt J, vanHaeringen A, Stolte-Dijkstra I, Kerstjens-Frederikse WS, Mancini GM, Wessels MW, Hennekam RC, Vreeburg M, Geraedts J, de Ravel T, Fryns JP, Smeets HJ, DevriendtK, Schrander-Stumpel CT. MLL2 mutation spectrum in 45 patients with Kabukisyndrome. Hum Mutat. 2011 Feb;32(2):E2018-25. doi: 10.1002/humu.21416.
More
©Text is available under the terms and conditions of the Creative Commons-Attribution ShareAlike (CC BY-SA) license; additional terms may apply. By using this site, you agree to the Terms and Conditions and Privacy Policy.
This entry is offline, you can click here to edit this entry!
Feedback